期刊文献+

PI-RADS v2.1和PI-RADS v2对移行带前列腺癌诊断价值的研究 被引量:14

Study of PI-RADS v2.1 and PI-RADS v2 for diagnostic value of transition zone prostate cancer
下载PDF
导出
摘要 目的研究PI-RADS v2.1和PI-RADS v2(第2.1版和第2版前列腺影像报告与数据系统)在移行带前列腺癌(prostate cancer,PCa)和临床显著性前列腺癌(clinically significant prostate cancer,csPCa)诊断中的价值。材料与方法回顾性分析108例[病理证实:PCa 53例、前列腺增生和(或)前列腺炎55例]病变位于移行带的患者的临床与影像资料。两名医师根据PI-RADS v2.1和PI-RADS v2对病灶评分。使用Kappa检验评估2名医师评分结果间的一致性;使用ROC曲线评估PI-RADS v2.1和PI-RADS v2对PCa、csPCa的诊断效能;采用Spearman相关分析对评分结果与Gleason评分的相关性进行分析。结果PI-RADS v2.1的一致性较PI-RADS v2有所提高(Kappa系数全部病变为0.794、0.724,csPCa病变为0.826、0.758,PCa病变为0.734、0.678);PI-RADS v2.1诊断PCa、csPCa的敏感度、准确度和AUC值及PCa的特异度均稍高于PI-RADS v2,P均>0.05;PI-RADS v2.1和PI-RADS v2评分结果均与Gleason评分呈中度正相关(r值分别为0.552和0.507,P均<0.05)。结论PI-RADS v2.1一致性更好,诊断效能不低于PI-RADS v2;PI-RADS评分可以指导穿刺,有助于评估肿瘤的侵袭性。 Objective:To study the diagnostic value of PI-RADS v2.1 and PI-RADS v2(prostate imaging reporting and data system version 2.1 and version 2)in diagnosing transition zone prostate cancer(PCa)and clinically significant prostate cancer(csPCa).Materials and Methods:The clinical and imaging data of 108 patients with transitional zone lesions(53 cases of PCa,55 cases of benign prostatic hyperplasia and/or inflammation)confirmed by pathology were analyzed retrospectively.Two radiologists independently scored the lesions according to PI-RADS v2.1 and PI-RADS v2.Kappa test was used to assess the consistency of the scoring results between two radiologists;ROC curve was used to evaluate and calculate the diagnostic efficiency of PI-RADS v2.1 and PI-RADS v2 for PCa and csPCa.Spearman correlation analysis was used to analyze the correlation between the scoring results and Gleason score.Results:The consistency of PI-RADS v2.1 was improved compared with PI-RADS v2(Kappa value was 0.794 vs.0.724 for all lesions,0.826 vs.0.758 for csPCa lesions,0.734 vs.0.678 for PCa lesions);the sensitivity,accuracy and AUC value of PI-RADS v2.1 in diagnosing PCa and csPCa and specificity of PI-RADS v2.1 in diagnosing PCa were slightly higher than those of PI-RADS v2(AUC:0.949 vs.0.922 for PCa,0.955 vs.0.931 for csPCa;sensitivity:0.981 vs.0.943 for PCa,0.978 vs.0.956 for csPCa;specificity:0.764 vs.0.745 for PCa),but the difference was not significant(all P>0.05);the scoring results of PI-RADS v2.1 and PI-RADS v2 were moderately positively correlated with Gleason score(r=0.552 vs.r=0.507,P<0.05).Conclusions:PI-RADS v2.1 has better consistency and the diagnostic efficiency is not lower than PI-RADS v2 for transition zone PCa and csPCa;the PI-RADS score can guide the puncture and help assess the aggressiveness of the tumor.
作者 张丹 朱子超 宋娜 王涛 于佳 蔡磊 陈志强 ZHANG Dan;ZHU Zichao;SONG Na;WANG Tao;YU Jia;CAI Lei;CHEN Zhiqiang(Department of Radiology,General Hospital of Ningxia Medical University,Yinchuan 750004,China;Clinical medicine school of Ningxia Medical University,Yinchuan 750004,China;Department of Genetics,School of Basic Medicine,Ningxia Medical University,Yinchuan 750004,China)
出处 《磁共振成像》 CAS CSCD 北大核心 2022年第1期54-58,共5页 Chinese Journal of Magnetic Resonance Imaging
基金 宁夏回族自治区重点研发计划项目(2019BEG03033) 宁夏自然科学基金项目(2020AAC03156)。
关键词 前列腺癌 前列腺影像报告与数据系统 GLEASON评分 多参数磁共振成像 prostate cancer prostate imaging reporting and data system Gleason score multi-parameter magnetic resonance imaging
  • 相关文献

参考文献7

二级参考文献55

  • 1徐明,周金良,盛惠珍.肿瘤标志物P504S在前列腺癌鉴别诊断中的价值[J].诊断学理论与实践,2004,3(4):273-276. 被引量:5
  • 2王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 3周桥.前列腺癌Gleason分级[J].中华病理学杂志,2005,34(4):240-243. 被引量:44
  • 4Egevad L, Mazzucehelli R, Montironi R. Implications of the International Society of Urological Pathology modified Gleason grading system[J]. Arch Pathol Lab Med,2012, 136 (4) :426- 434. DOI : 10. 5858/arpa. 20114)495-RA.
  • 5Epstein JI, Zelefsky MJ, Sjoberg DD, et al. A contemporary prostate cancer grading system: a validated alternative to the Gleason Score[J]. Eur Urol,2016,69(3):428-435. DOI: 10. 1016/j. eururo. 2015.06. 046.
  • 6Epstein JI, Feng Z, Trock B J, et al. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy : incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades [ J]. Eur Urol,2012,61 (5) : 1019- 1024. DOI : 10. 1016/j. eururo. 2012.01. 050.
  • 7Epstein JI. An update of the Gleason grading system[ J]. J Urol, 2010,183 (2) :433440. DOI: 10. 1016@ juro. 2009.10. 046.
  • 8Brimo F, Montironi R, Egevad L, et al. Contemporary grading for prostate cancer: implications for patient care[ J]. Eur Urol,2015, 63(5) :892-901. DOI: 10. 1016/j. eururo. 2012.10.015.
  • 9Waliszewski P, Wagenlehner F, Kribus S, et al. Objective grading of prostate carcinoma based on fractal dimensions : Gleason 3 +g =7a not equal Gleason 4 +3 =7b] [J]. Urologe A,2014,53 (10) : 1504-1511. DOI : 10. 1007/s00120-O14-3470-z.
  • 10Brockman JA, Alanee S, Vickers AJ, et al. Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy [ J ] Eur Urol, 2015,67 (6) :1160-1167. DOI: 10. 1016/j. eumro. 2014. 09. 019.

共引文献940

同被引文献131

引证文献14

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部